14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
18
Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
Acadia Pharmaceuticals
11
Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.
Acadia Pharmaceuticals
12
Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
Acadia Pharmaceuticals
23
Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.
Acadia Pharmaceuticals
12
Discovery of potent and selective small-molecule PAR-2 agonists.
Acadia Pharmaceuticals
3
Multistep solution-phase parallel synthesis of spiperone analogues.
Acadia Pharmaceuticals
9
Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
Acadia Pharmaceuticals
1
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).
Acadia Pharmaceuticals
90
Compounds, salts thereof and methods for treatment of diseases
Acadia Pharmaceuticals
5
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.
Acadia Pharmaceuticals
40
Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
Acadia Pharmaceuticals
3
Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist.
Acadia Pharmaceuticals